Repair Biotechnologies’ REP-0004 mRNA therapy gains FDA orphan drug designation and demonstrates rapid plaque regression in mouse models, potentially revolutionizing cardiovascular care. An mRNA...
MIT-led study in Nature Biotechnology uses mRNA-lipid nanoparticles to convert dendritic cells into potent cancer fighters, achieving complete tumor regression in mice. mRNA-loaded nanoparticles repro...
MIT researchers used mRNA to reprogram dendritic cells, achieving complete tumor regression in over 70% of mice with durable immune memory. A new MIT-led study published in Nature Biotechnology demons...
Recent research shows lipid nanoparticles delivering mRNA can reduce tau protein aggregates in Alzheimer’s models, with Moderna advancing clinical trials and regulatory support accelerating deve...